Vulvovaginal candidiasis (VVC) is an infection of the genital mucosa caused by different species of the genus Candida. The objective of this study is to evaluate the pathogenicity of Candida spp associated with the production of iopilm and resistance to antifungals such as fluconazole, itraconazole, miconazole and nystatin in the cervical vaginal mucosa of women with recurrent candidiasis in two medical centers in the city of Bogotá D.C. The samples will be collected by a clinical gynecologist from the Clínica de la Mujer and the Hospital Universitario San Ignacio and identified by mass spectrometry (MALDI-TOF). The susceptibility analysis will be performed using the technique of Minimum Inhibitory Concentration (MIC) by microtitration according to the CLSI M27-A2 protocol, to determine and relate the capacity of biofilm formation with the virulence of the strains will be performed the analysis of Biofilm formation with the XTT reagent, after that we will analyze the expression of genes involved in biofilm synthesis. With these analyses we will be able to correlate the biofilm production capacity with the resistance and virulence of the different clinical strains obtained from women with recurrent candidiasis.
|Effective start/end date||1/2/18 → 1/9/20|
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Installed Capacity (Academic Unit)
- Bogotá D.C.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.